RJA
ETON icon

Raymond James & Associates’s Eton Pharmaceutcials ETON Stock Holding History

Raymond James & Associates’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$61.5K Hold
10,250
– – ﹤0.01% 3833
2024
Q2 		$33.7K Hold
10,250
– – ﹤0.01% 3837
2024
Q1 		$38.4K Buy
10,250
+150
+1% +$655 ﹤0.01% 3827
2023
Q4 		$44.2K Buy
10,100
+100
+1% +$401 ﹤0.01% 3718
2023
Q3 		$41.7K Hold
10,000
– – ﹤0.01% 3689
2023
Q2 		$34.9K Hold
10,000
– – ﹤0.01% 3733
2023
Q1 		$38.5K Buy
+10,000
New +$36.5K ﹤0.01% 3754

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's ETON Position: Q3 2024 in Review

Raymond James & Associates held its Eton Pharmaceutcials (ETON) position steady in Q3 2024 at 10,250 shares worth $61.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3833.

Raymond James & Associates first reported a position in ETON in Q1 2023 and has held it in 7 quarters since. 48 funds tracked by Wall St. Rank hold ETON as of Q3 2024.

  • Raymond James & Associates held 10,250 shares of Eton Pharmaceutcials worth $61.5K as of Q3 2024.
  • Raymond James & Associates left its Eton Pharmaceutcials share count unchanged in Q3 2024.
  • Eton Pharmaceutcials made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3833 holding.
  • Raymond James & Associates first reported a position in Eton Pharmaceutcials in Q1 2023 and has held it in 7 quarters since.
  • 48 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.